Successful Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment in a HIV Patient With Swallowing Difficulties

Ann Pharmacother. 2021 Apr;55(4):556-557. doi: 10.1177/1060028020953631. Epub 2020 Aug 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adenine / pharmacokinetics
  • Alanine
  • Amides
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / pharmacokinetics
  • Deglutition / drug effects*
  • Deglutition / physiology
  • Drug Combinations
  • Emtricitabine / administration & dosage*
  • Emtricitabine / pharmacokinetics
  • Female
  • Fruit and Vegetable Juices*
  • HIV Infections / drug therapy
  • HIV Infections / metabolism
  • Heterocyclic Compounds, 3-Ring
  • Heterocyclic Compounds, 4 or More Rings / administration & dosage*
  • Heterocyclic Compounds, 4 or More Rings / pharmacokinetics
  • Humans
  • Middle Aged
  • Piperazines
  • Pyridones
  • Solubility
  • Tenofovir / analogs & derivatives

Substances

  • Amides
  • Anti-HIV Agents
  • Drug Combinations
  • Heterocyclic Compounds, 3-Ring
  • Heterocyclic Compounds, 4 or More Rings
  • Piperazines
  • Pyridones
  • bictegravir
  • Tenofovir
  • tenofovir alafenamide
  • Emtricitabine
  • Adenine
  • Alanine